R. Little, D. Pearson, G. Franchini, S. Steinberg, P. Elwood, R. Yarchoan, W. Wilson (1999)
Dose-Adjusted EPOCH Chemotherapy (CT) in Previously Untreated HIV-Associated Non-Hodgkin's Lymphoma (HIV-NHL): Preliminary Report of Efficacy, Immune Reconstitution, and HIV Control Following Therapy.Journal of Acquired Immune Deficiency Syndromes, 21
J. Evison, J. Jost, B. Ledergerber, L. Jost, F. Strasser, R. Weber (1999)
HIV-associated non-Hodgkin's lymphoma: highly active antiretroviral therapy improves remission rate of chemotherapy.AIDS, 13 6
MD Carpenter, MD Cooper, MD Fischl, MD Gatell, MA Gazzard, MD Hammer, MD Hirsch, MD Jacobsen, BS Katzenstein, MD Montaner, MD Richman, M. Saag, MD Schechter, PhD Schooley, MD Thompson, MD Vella, MD Yeni, MD Volberding, MD CharlesC.J.Car-penter (2000)
Antiretroviral Therapy in Adults Updated Recommendations of the International AIDS Society–USA Panel
U. Tirelli, D. Errante, É. Oksenhendler, M. Spina, E. Vaccher, D. Serraino, R. Gastaldi, L. Repetto, G. Rizzardini, A. Carbone, G. Bertola, E. Mandelli, S. Monfardini, C. Gisselbrecht (1992)
Prospective study with combined low-dose chemotherapy and zidovudine in 37 patients with poor-prognosis AIDS-related non-Hodgkin's lymphoma. French-Italian Cooperative Study Group.Annals of oncology : official journal of the European Society for Medical Oncology, 3 10
A. Leandersson, G. Bratt, J. Hinkula, G. Gilljam, P. Cochaux, M. Samson, E. Sandström, B. Wahren (1998)
Induction of specific T‐cell responses in HIV infectionAIDS, 12
N. Harris (1994)
A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group.Blood, 84 5
G. Matthews, M. Bower, S. Mandalia, T. Powles, Mark Nelson, B. Gazzard (2000)
Changes in acquired immunodeficiency syndrome-related lymphoma since the introduction of highly active antiretroviral therapy.Blood, 96 8
Kaplan Ld, D. Abrams, E. Feigal, M. McGrath, J. Kahn, Padraic Neville, J. Ziegler, P. Volberding (1989)
AIDS-associated non-Hodgkin's lymphoma in San Francisco.JAMA, 261 5
D. Straus, Jie Huang, M. Testa, Alexandra Levine, L. Kaplan (1998)
Prognostic factors in the treatment of human immunodeficiency virus-associated non-Hodgkin's lymphoma: analysis of AIDS Clinical Trials Group protocol 142--low-dose versus standard-dose m-BACOD plus granulocyte-macrophage colony-stimulating factor. National Institute of Allergy and Infectious DiseasJournal of clinical oncology : official journal of the American Society of Clinical Oncology, 16 11
Harris (1994)
10.1182/blood.V84.5.1361.1361Blood, 84
M. Jacobson, M. French (1998)
Altered natural history of AIDS-related opportunistic infections in the era of potent combination antiretroviral therapy.AIDS, 12 Suppl A
Kaplan Ld, J. Kahn, S. Crowe, D. Northfelt, Padraic Neville, H. Grossberg, D. Abrams, Julie Tracey, J. Mills, P. Volberding (1991)
Clinical and virologic effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients receiving chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma: results of a randomized trial.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 9 6
B. Ledergerber, A. Telenti, M. Egger (1999)
Risk of HIV related Kaposi's sarcoma and non-Hodgkin's lymphoma with potent antiretroviral therapy: prospective cohort studyBMJ, 319
U. Tirelli, M. Spina, J. Gabarre, G. Rizzardini, D. Schlaifer, E. Nigra, R. Bouabdallah, M. Schrappe, C. Arbone, M. Raphael, C. Gisselbrecht (1999)
TREATMENT OF HIV-RELATED NON-HODGKIN'S LYMPHOMA ADAPTED TO PROGNOSTIC FACTORS.Journal of Acquired Immune Deficiency Syndromes, 21
T. Elbeik, E. Charlebois, P. Nassos, J. Kahn, F. Hecht, D. Yajko, Valerie Ng, K. Hadley (2000)
Quantitative and Cost Comparison of Ultrasensitive Human Immunodeficiency Virus Type 1 RNA Viral Load Assays: Bayer bDNA Quantiplex Versions 3.0 and 2.0 and Roche PCR Amplicor Monitor Version 1.5Journal of Clinical Microbiology, 38
S. Michaels, R. Clark, P. Kissinger (1998)
Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection.The New England journal of medicine, 339 6
U. Tirelli, D. Errante, M. Spina, R. Gastaldi, E. Nigra, A. Nosari, G. Magnani, E. Vaccher, For Tumo (1996)
Second‐line chemotherapy in human immunodeficiency virus‐related non‐Hodgkin's lymphoma: Evidence of activity of a combination of etoposide, mitoxantrone, and prednimustine in relapsed patientsCancer, 77
Matthews (2000)
10.1182/blood.V96.8.2730Blood, 96
E. Kaplan, P. Meier (1958)
Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 53
F. Palella, K. Delaney, A. Moorman, M. Loveless, J. Fuhrer, G. Satten, D. Aschman, S. Holmberg (1998)
Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators.The New England journal of medicine, 338 13
J. Sparano, Xiaoping Hu, Peter Wiernik, Catherine Sarta, D. Reddy, Larry Hanau, David Henry (1997)
Opportunistic infection and immunologic function in patients with human immunodeficiency virus-associated non-Hodgkin's lymphoma treated with chemotherapy.Journal of the National Cancer Institute, 89 4
R. Meyer, W. Hryniuk, M. Goodyear (1991)
The role of dose intensity in determining outcome in intermediate-grade non-Hodgkin's lymphoma.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 9 2
F. Thiessard, P. Morlat, C. Marimoutou, E. Labouyrie, J. Ragnaud, J. Pellegrin, M. Dupon, F. Dabis (2000)
Prognostic factors after non‐Hodgkin lymphoma in patients infected with the human immunodeficiency virusCancer, 88
L. Kaplan, D. Straus, M. Testa, J. Roenn, B. Dezube, T. Cooley, B. Herndier, D. Northfelt, J.E. Huang, A. Tulpule, Alexandra Levine (1997)
Low-dose compared with standard-dose m-BACOD chemotherapy for non-Hodgkin's lymphoma associated with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group.The New England journal of medicine, 336 23
C. Gisselbrecht, É. Oksenhendler, U. Tirelli, É. Lepage, J. Gabarre, J. Farcet, Roberta Gastaldi, B. Coiffier, A. Thyss, M. Raphael, S. Monfardini (1993)
Human immunodeficiency virus-related lymphoma treatment with intensive combination chemotherapyThe American Journal of Medicine, 95
N. Breslow, N. Day (1980)
The analysis of case-control studies
(2000)
10.1001/jama.283.3.381JAMA, 283
S. Buchbinder, S. Holmberg, S. Scheer, G. Colfax, P. O'Malley, E. Vittinghoff (1999)
Combination antiretroviral therapy and incidence of AIDS-related malignancies.Journal of acquired immune deficiency syndromes, 21 Suppl 1
J. Sparano, P. Wiernik, Xiaoping Hu, C. Sarta, Edward Schwartz, Ruy Soeiro, David Henry, Bernard Mason, Howard Ratech, J. Dutcher (1996)
Pilot trial of infusional cyclophosphamide, doxorubicin, and etoposide plus didanosine and filgrastim in patients with human immunodeficiency virus-associated non-Hodgkin's lymphoma.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 14 11
L. Jacobson, T. Yamashita, R. Detels, J. Margolick, J. Chmiel, Kingsley La, S. Melnick, A. Muñoz (1999)
Impact of potent antiretroviral therapy on the incidence of Kaposi's sarcoma and non-Hodgkin's lymphomas among HIV-1-infected individuals. Multicenter AIDS Cohort Study.Journal of acquired immune deficiency syndromes, 21 Suppl 1
E. Vaccher, M. Spina, R. Talamini, A. Lucenti, D. Errante, M. Tavio, G. Nasti, S. Santarossa, U. Tirelli (1998)
CONCOMITANT CHOP CHEMOTHERAPY (CT) AND HIGHLY ACTIVE ANTIRETROVIRAL THERAPY (HAART) IN PATIENTS (PTS) WITH HIV-RELATED NON-HODGKIN'S LYMPHOMA (HIV-NHL).Journal of Acquired Immune Deficiency Syndromes, 17
W. Hryniuk, H. Bush (1984)
The importance of dose intensity in chemotherapy of metastatic breast cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2 11
(1999)
Effect of antiretroviral therapy on recent trends in selected cancers among HIVinfected persons
Kaplan (1958)
10.2307/2281868J Am Stat Assoc, 53
Kaplan (1989)
10.1001/jama.261.5.719JAMA, 261
C. Rabkin, M. Testa, Jie Huang, J. Roenn (1999)
Kaposi's sarcoma and non-Hodgkin's lymphoma incidence trends in AIDS Clinical Trial Group study participants.Journal of acquired immune deficiency syndromes, 21 Suppl 1
A. Levine, J. Sullivan‐Halley, M. Pike, M. Rarick, C. Loureiro, M. Bernstein‐Singer, E. Willson, R. Brynes, J. Parker, S. Rasheed, P. Gill (1991)
Human immunodeficiency virus‐related lymphoma. Prognostic factors predictive of survivalCancer, 68
AIDS – Unpaywall
Published: Aug 1, 2001
Access the full text.
Sign up today, get DeepDyve free for 14 days.